Nov 1, 2023 · Author Bios. Dr. Lori M. Minasian is deputy director for the Division of Cancer Prevention at the National Cancer Institute.. Dr. Paul F. Pinsky is chief of the Early Detection Research Branch for the Division of Cancer Prevention at the National Cancer Institute.. Dr. Christos Patriotis is a program officer in the Cancer Biomarkers Research Group for the Division of Cancer Prevention at the ...

Aug 21, 2019 · Dr. Clifford Hudis. Clifford A. Hudis, MD, FACP, FASCO, CEO of ASCO, recently interviewed Lisa Lacasse, president of the American Cancer Society Cancer Action Network, as part of the ASCO in Action Podcast series.

Apr 3, 2024 · Dr. Vanya Aggarwal. Key Points: The third-generation EGFR tyrosine kinase inhibitor (TKI) osimertinib, which has shown survival benefits in patients with resected EGFR-mutant non–small cell lung cancer (NSCLC), was approved as adjuvant therapy by the U.S. Food and Drug Administration in 2020.; Recently, the randomized ALINA trial demonstrated a significant disease-free survival (DFS) benefit ...

Mar 18, 2024 · ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual. ASCO Guidelines follow ...

The JCO Resource Center provides an opportunity to align your message with the world’s most authoritative and trusted content in clinical oncology.

May 18, 2023 · Oral cavity cancer (OCC) accounts globally for an estimated 377,000 new cases yearly (2% of all cancers) and over 177,000 deaths (1.8% of all cancers). 1 Almost 90% of these cancers are squamous cell carcinomas. 2 There are noticeable geographic disparities in the incidence of oral cavity squamous cell carcinoma (OSCC) with approximately two thirds of the cases occurring in the developing ...

There were approximately 725,000 new cases and 664,000 deaths worldwide due to hepatocellular carcinoma (HCC) in 2020. HCC comprises 75%-85% of primary liver cancer cases and is the fourth-leading cause of annual cancer deaths worldwide. 1 In the United States, it is estimated that liver cancer will account for approximately 41,210 new cases and about 29,380 deaths in 2023. 2 Risk factors vary ...

In the United States, the Controlled Substance Act renders cannabis with >0.3% delta-9-tetrahydrocannabinol (THC) schedule I. This status signifies that cannabis has no accepted medical use and a high potential for abuse. 20 The schedule I designation creates frequent conflicts between federal and state laws, as 38 states now allow medical cannabis use by adults with qualifying conditions.

May 15, 2024 · Brain metastases (BMs) occur in 20%-40% of patients with breast cancer during the course of their disease. 1 BMs from solid tumors contribute significantly to morbidity and/or mortality, with about 200,000 patients—10% of all patients with cancer—diagnosed each year in the United States. 2 Notably, Breast Cancer BMs (BCBM) represents second most common (30%) among all cancers. 3 With ...

Background: Across a variety of malignancies, sites of metastatic involvement are known to be associated with differences in survival. We sought to characterize the frequency and survival of patients with different sites of metastases in mRCC. Methods: Patients with mRCC starting treatment between 2002-2019 were identified and sites of metastatic involvement at time of systemic therapy ...